GT Medical Technologies
Tempe
About GT Medical Technologies
GT Medical Technologies is a medical device company, is focused on improving the lives of patients with brain tumors. GT has developed an innovative approach to treatment by combining a conformable collagen matrix with brachytherapy (radiation) seeds. The company's first product, GammaTile™ is protected by 10 US and 2 Canadian-issued patents, and 1 EPO patent. The product has the promise to revolutionize treatment for 176,000 patients/year in the US alone. To date, we have treated 120 patients with recurrent brain tumors in a clinical trial at Barrow Neurological Institute (BNI) and observed significant clinical improvement.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $162.5M
- Funding stage: Late Stage Venture
- Last round: Series D (Jan 2025)
- Website: gtmedtech.com
- Phone: 1.833.662.0044
Industries & Categories
Health Care, Medical, Medical Device, Neuroscience, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/gt-medical-technologies-117998 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.